Bedsore
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Bedsore Classification and external resources | |
 | |
|---|---|
| Pressure ulcer: Unstageable | |
| ICD-10 | L89. |
| ICD-9 | 707.0 |
| DiseasesDB | 10606 |
| eMedicine | med/2709 |
| MeSH | D003668 |
|
WikiDoc Resources for Bedsore | |
|
Articles | |
|---|---|
|
Most recent articles on Bedsore | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Bedsore at Clinical Trials.gov Clinical Trials on Bedsore at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Bedsore
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Directions to Hospitals Treating Bedsore Risk calculators and risk factors for Bedsore
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Bedsore | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-in-Chief: Angela Botts, M.D., Beth Israel Deaconess Medical Center Geriatric Medicine [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Introduction
Bedsores, more properly known as pressure ulcers or decubitus, are lesions caused by unrelieved pressure to any part of the body, especially portions over bony or cartilaginous areas. Although completely treatable if found early, without medical attention, bedsores can become life-threatening.
Classification
The definitions of the four pressure ulcer stages are revised periodically by the National Pressure Ulcer Advisory Panel (NPUAP) in the United States. Briefly, however, they are as follows:
- Stage I is the most superficial, indicated by redness that does not subside after pressure is relieved. This stage is visually similar to reactive hyperemia (a technical term for excessive redness) seen in skin after prolonged application of pressure. Stage I pressure ulcers can be distinguished from reactive hyperemia in two ways: a) reactive hyperemia resolves itself within 3/4 of the time pressure was applied, and b) reactive hyperemia blanches when pressure is applied, whereas a Stage I pressure ulcer does not. The skin may be hotter or cooler than normal, have an odd texture, or perhaps be painful to the patient. Although easy to identify on a light-skinned patient, ulcers on darker-skinned individuals may show up as shades of purple or blue in comparison to lighter skin tones.
- Stage II is damage to the epidermis extending into, but no deeper than, the dermis. In this stage, the ulcer may be referred to as a blister or abrasion.
- Stage III involves the full thickness of the skin, extending into, but not through, the subcutaneous tissue layer. This layer has a relatively poor blood supply and can be difficult to heal. At this stage, there may be undermining that makes the wound much larger than it may seem on the surface.
- Stage IV is the deepest, extending into the muscle, tendon or even bone.
- Unstageable pressure ulcers are covered with dead cells, or eschar and wound exudate, so the depth cannot be determined.
With higher stages, healing time is prolonged. While about 75% of Stage II ulcers heal within eight weeks, only 62% of Stage IV pressure ulcers ever heal, and only 52% heal within one year.[1] It is important to note that pressure ulcers do not regress in stage as they heal. A pressure ulcer that is becoming shallower with healing is described in terms of its original deepest depth (e.g., healing Stage II pressure ulcer).
Etiology
Bedsores are accepted to be caused by three different tissue forces:
- Pressure, or the compression of tissues. In most cases, this compression is caused by the force of bone against a surface. After an extended amount of time with decreased tissue perfusion, ischemia occurs and can lead to tissue necrosis if left untreated in an immunocompromised patient.
- Shear force, or a force created when the skin of a patient stays in one place as the deep fascia and skeletal muscle slide down with gravity. This can also cause the pinching off of blood vessels which may lead to ischemia and tissue necrosis.
- Friction, or a force resisting the shearing of skin. This may cause excess shedding through layers of epidermis.
Aggravating the situation may be other conditions such as excess moisture from incontinence, perspiration or exudate. Over time, this excess moisture may cause the bonds between epithelial cells to weaken thus resulting in the maceration of the epidermis. Other factors in the development of bedsores include age, nutrition, vascular disease, diabetes mellitus, and smoking, amongst others.
There are currently two major theories about the development of pressure ulcers. The first and most accepted is the deep tissue injury theory which claims that the ulcers begin at the deepest level, around the bone, and move outward until they reach the epidermis. The second, less popular theory is the top-to-bottom model which says that skin first begins to deteriorate at the surface and then proceeds inward.[1]
Pathophysiology
Pressure ulcers may be caused by inadequate blood supply and resulting reperfusion injury when blood re-enters tissue. A simple example of a mild pressure sore may be experienced by healthy individuals while sitting in the same position for extended periods of time: the dull ache experienced is indicative of impeded blood flow to affected areas. Within hours, this shortage of blood supply, called ischemia, may lead to tissue damage and cell death. The sore will initially start as a red, painful area, which eventually turns purple. Left untreated, the skin may break open and become infected. Moist skin is more sensitive to tissue ischemia and necrosis and is also more likely to get infected.
Epidemiology
Within acute care, the incidence of bedsores is 0.4% to 38%; within long-term care, 2.2% to 23.9%; and in home care, 0% to 17%. There is the same wide variation in prevalence: 10% to 18% in acute care, 2.3% to 28% in long-term care, and 0% to 29% in home care. There is a much higher rate of bedsores in intensive care units because of immunocompromised individuals, with 8% to 40% of ICU patients developing bedsores.[1]
The risk of developing bedsores can be determined by using the Braden Scale for Predicting Pressure Ulcer Risk. This scale is divided into six risk categories:
- sensory perception
- moisture
- activity
- mobility
- nutrition
- friction and shear
The best possible interpretation is a score of 23 whilst the worst is a 6. If the total score is below 11, the patient is at risk for developing bedsores.[1]
Treatment
The most important thing to keep in mind about the treatment of bedsores is that the most optimal outcomes find their roots in a multidisciplinary approach; by using a team of specialists, there is a better chance that all bases will be covered in treatment.
There are six major contributors to healing.
Debridement
The removal of necrotic tissue is an absolute must in the treatment of pressure sores. Because dead tissue is an ideal area for bacteria growth, it has the ability to greatly compromise wound healing. There are at least seven ways to excise necrotic tissue.[1]
- Autolytic debridement is the use of moist dressings to promote autolysis with the body's own enzymes. It is a slow process, but mostly painless.
- Biological debridement, or maggot debridement therapy, is the use of medical maggots to feed on necrotic tissue and therefore clean the wound of excess bacteria. Although this fell out of favour for many years, in January 2004, the FDA approved maggots as a live medical device.[1]
- Chemical debridement, or enzymatic debridement, is the use of prescribed enzymes that promote the removal of necrotic tissue.
- Mechanical debridement is the use of outside force to remove dead tissue. A quite painful method, this involves the packing of a wound with wet dressings that are allowed to dry and then are removed. This in also unpopular because it has the ability to remove healthy tissue in addition to dead tissue. Lastly, with Stage IV ulcers, there is the chance that overdrying of the dressings can lead to bone fractures and ligament snaps.
- Sharp debridement is the removal of necrotic tissue with a scalpel or similar instrument.
- Surgical debridement is the most popular method, as it allows a surgeon to quickly remove dead tissue with little pain to the patient.
- Ultrasound-assisted wound therapy is the use of ultrasound waves to separate necrotic and healthy tissue.
Infection control
Infection has one of the greatest effects on the healing of a wound. Purulent discharge provides a breeding ground for excess bacteria, a problem especially in the immunocompromised patient. Symptoms of systemic infection include fever, pain, erythema, oedema, and warmth of the area, not to mention purulent discharge. Additionally, infected wounds may have a gangrenous smell, be discoloured, and may eventually exude even more pus.
In order to eliminate this bioburden, it is imperative to apply antiseptics and antimicrobials at once. It is not recommended to use hydrogen peroxide for this task as it is difficult to balance the toxicity of the wound with this. New dressings have been developed that have cadexomer iodine and silver in them, and they are used to treat bad infections. Duoderm can be used on smaller wounds to both provide comfort and protect them from outside air and infections.
It is not recommended to use systemic antibiotics to treat infection of a bedsore, as it can lead to bacterial resistance.
Nutritional support
Upon admission, the patient should have a consultation with a dietitian to determine the best diet to support healing, as a malnourished person does not have the ability to synthesize enough protein to repair tissue. The dietition should conduct a nutritional assessment that includes a battery of questions and a physical examination. If malnourishment is suspected, lab tests should be run to check serum albumin and lymphocyte counts. Additionally, a bioelectric impedance analysis should be considered.
If the patient is found to be at risk for malnutrition, it is imperative to begin nutritional intervention with dietary supplements and nutrients including, but not limited to, arginine, glutamine, vitamin A, vitamin B complex, vitamin E, vitamin C, magnesium, manganese, selenium and zinc. It is very important that intake of these vitamins and minerals be overseen by a physician, as many of them can be detrimental in incorrect dosages.
How to properly care for a bedsore
The most important care for a patient with bedsores is the relief of pressure. Once a bedsore is found, pressure should immediately be lifted from the area and the patient turned at least every two hours to avoid aggravating the wound. Nursing homes and hospitals usually set programs to avoid the development of bedsores in bedridden patients such as using a standing frame to reduce pressure and ensuring dry sheets by using catheters or impermeable dressings. For individuals with paralysis, pressure shifting on a regular basis and using a cushion featuring pressure relief components can help prevent pressure wounds.
Pressure-distributive mattresses are used to reduce high values of pressure on prominent or bony areas of the body. However, methods to evaluate the efficacy of these products have only been developed in recent years.[1]
Educating the caregiver
In the case that the patient will be returning to home care, it is very important to educate the family about how to treat their loved one's pressure ulcers. The cross-specialisation wound team should train the caregiver in the proper way to turn the patient, how to properly dress the wound, how to properly nourish the patient, and how to deal with crisis, among other things.
As this is a very difficult undertaking, the caregiver may feel overburdened and depressed, so it may be best to bring in a psychological consult.
Wound intervention
Once the patient has reached the point that intervention is possible, there are many different options. For patients with Stages I and II ulcers, the wound care team should use guidelines established by the American Medical Directors Association (AMDA) for the treatment of these low-grade sores.
For those with Stage III or IV ulcers, most interventions will likely include surgery such as a tissue flap, skin graft or other closure methods. A more recent intervention is Negative Pressure Wound Therapy, which is the application of topical negative pressure to the wound. This technique, developed by scientists at Wake Forest University, uses foam placed into the wound cavity which is then covered in a film which creates an airtight seal. Once this seal is established, the technician is able to remove exudate and other infectious materials in addition to aiding the body produce granulation tissue, the best bed for the creation of new skin.
There are, unfortunately, contraindications to the use of negative pressure therapy. Most deal with the unprepared patient, one who has not gone through the previous steps toward recovery, but there are also wound characteristics that bar a patient from participating: a wound with inadequate circulation, a raw debridled wound, a wound with necrotised tissue and eschar, and a fibrotic wound.
After Negative Pressure Wound Therapy, the patient should be reevaluated every two weeks to determine future therapy.
Complications
Pressure sores can trigger other ailments, and cause patients considerable suffering and financial cost.[1] Some complications include autonomic dysreflexia, bladder distension, osteomyelitis, pyarthroses, sepsis, amyloidosis, anemia, urethral fistula, gangrene and very rarely malignant transformation. Sores often recur because patients do not follow recommended treatment or develop seromas, hematomas, infections, or dehiscence. Paralytic patients are the most likely people to have pressure sores recur. In some cases, complications from pressure sores can be life-threatening. The most common causes of fatality stem from renal failure and amyloidosis.
See also
References
Alexander's Care of the Patient in Surgery by Jane C Rothrock, Thirteenth Edition, 2007. Mosby
External links
- Bed Sores and Pressure Ulcers
- Bed Sores and Pressure Ulcers
- Maggot Therapy Project web site at the University of California, Irvine, list of maggot therapy practitioners
- BioTherapeutics Education and Research Foundation
- CNN article
- USA today article
- Kinetic Concepts, Inc. - VAC Therapy
Geriatrics | |
|---|---|
| Health in Geriatrics | Physical activity in the elderly • Nutrition and diet in the elderly • Hypertension in the elderly • Sexual function in the elderly • Cardiovascular disease prevention in the elderly • Respiratory disease and flu prevention in the elderly • Cancer screening in the elderly • Endocrine function and metabolism in the elderly • Longevity • Rejuvenation • Anti-aging • Nursing in the elderly • Physical therapy and rehabilitation • Myocardial infarction in the elderly • Bladder control problems • Encopresis • Bening prostatic hypertrophy • Pressure ulcers |
| Psychiatric conditions | Dementia • Delirium • Depression • Sleep disorders • Memory loss • |
| Palliative care | Hearing impairment • Visual impairment • |
| Cardiovascular system | Hypertension • Syncope • Coronary artery disease • Myocardial infarction • Peripheral arterial disease • Carotid bruit • Heart murmurs • Chest pain • Syncope in the elderly |
| Respiratory system | Dyspnea • Orthopnoea • Stridor • Wheeze • Hyperventilation • Mouth breathing • Hiccup • Bradypnea • Hypoventilation • Asphyxia • Pleurisy • Respiratory arrest • Sputum • Rales • |
| Oncology related issues | Hyperplasia • Cyst • Pseudocyst • Hamartoma • Benign tumor • Colorectal cancer • Dysplasia • Carcinoma in situ • Cancer • Metastasis • Oral • Head/Neck • Nasopharyngeal • Staging/grading • Carcinogenesis • Carcinogen • Research • Paraneoplastic syndrome
Digestive system: (Esophagus • Stomach • Small intestine • Colon/rectum • Appendix • Anus) • glands (Liver • Bile duct • Gallbladder • Pancreas) Respiratory system: Larynx • Lung • Bone, articular cartilage, skin, and connective tissue: Bone • (Tailbone) • Skin • Blood Urogenital: Breast and female genital organs (Breast • Vagina • Cervix, Uterus • Endometrium • Ovaries) Male genital organs (Penis • Prostate • Testicles) • urinary organs (Kidney • Bladder) Nervous system: Eye • (Uvea) • Brain • (Choroid plexus) Endocrine system: Thyroid (Papillary • Follicular, Medullary • Anaplastic) • Adrenal tumor • (Adrenocortical carcinoma • Pheochromocytoma) • Pituitary |
| Neurological system | Alzheimer disease • Parkinson's disease • Stroke • |
| Rheumatologic and Musculosceletal system | Difficulty walking • Falls and Injuries • Arthritis • Sarcopenia • |
| Hepatic and Gastrointestinal system | Difficulty swallowing • Malnutrition • |
| Endocrine system and metabolism | Diabetes mellitus • Thyroid disease • Osteoporosis • |
WikiDoc Research Resources for Bedsore | |
|---|---|
| Articles on Bedsore | Most recent articles on Bedsore • Most cited articles on Bedsore • Review articles on Bedsore • Articles on Bedsore in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Bedsore | Powerpoint slides on Bedsore • Images of Bedsore • Photos of Bedsore • Podcasts & MP3s on Bedsore • Videos on Bedsore |
| Evidence Based Medicine Regarding Bedsore | Cochrane Collaboration on Bedsore • Bandolier on Bedsore • TRIP on Bedsore |
| Cost Effectiveness of Bedsore | Cost Effectiveness of Bedsore |
| Clinical Trials Involving Bedsore | Ongoing Trials on Bedsore at Clinical Trials.gov • Trial results on Bedsore • Clinical Trials on Bedsore at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Bedsore | US National Guidelines Clearinghouse on Bedsore • NICE Guidance on Bedsore • NHS PRODIGY Guidance • FDA on Bedsore • CDC on Bedsore |
| Textbook Information on Bedsore | Books and Textbook Information on Bedsore |
| Pharmacology Resources on Bedsore | Dosing of Bedsore • Drug interactions with Bedsore • Side effects of Bedsore • Allergic reactions to Bedsore • Overdose information on Bedsore • Carcinogenicity information on Bedsore • Bedsore in pregnancy • Pharmacokinetics of Bedsore • |
| Genetics, Pharmacogenomics, and Proteinomics of Bedsore | Genetics of Bedsore • Pharmacogenomics of Bedsore • Proteomics of Bedsore |
| Newstories on Bedsore | Bedsore in the news • Be alerted to news on Bedsore • News trends on Bedsore |
| Commentary on Bedsore | Blogs on Bedsore |
| Patient Resources on Bedsore | Patient resources on Bedsore • Discussion groups on Bedsore • Patient Handouts on Bedsore • Directions to Hospitals Treating Bedsore • Risk calculators and risk factors for Bedsore |
| Healthcare Provider Resources on Bedsore | Symptoms of Bedsore • Causes & Risk Factors for Bedsore • Diagnostic studies for Bedsore • Treatment of Bedsore |
| Continuing Medical Education (CME) Programs on Bedsore | CME Programs on Bedsore |
| International Resources on Bedsore | Bedsore en Espanol • Bedsore en Francais |
| Business Resources on Bedsore | Bedsore in the Marketplace • Patents on Bedsore |
| Informatics Resources on Bedsore | List of terms related to Bedsore |
ar:قرحة فراش
de:Dekubitus
fr:Escarre
hr:Dekubitus
it:Lesione da decubito
he:פצע לחץ
nl:Decubitus
ja:褥瘡
no:Trykksårsk:Preležanina
fi:Makuuhaava
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
